Regentis Biomaterials (RGNT) Assets Average (2025)

Regentis Biomaterials' (RGNT) quarterly Assets Average came in at $4.0 million in Q4 2025.

Regentis Biomaterials (RGNT) Assets Average (2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 1 years of Assets Average data on file, last reported at $4.0 million in Q4 2025.

  • On a quarterly basis, Assets Average changed N/A year-over-year to $4.0 million in Q4 2025; TTM through Dec 2025 was $4.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.0 million, changed N/A from the prior year.
  • Assets Average for Q4 2025 stood at $4.0 million.
  • Over the last five years, Assets Average for RGNT reached as high as $4.0 million in Q4 2025 and fell as low as $4.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 31.59 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 20.49 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 52.84 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 38.75 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 8.64 Bn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.09 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 12.45 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 14.20 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 6.27 Bn
10 Regentis Biomaterials 1.10 Mn -6.28 Mn - 4.05 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.05 Mn